Relmada Therapeutics (RLMD) Other Working Capital Changes (2012 - 2026)
Relmada Therapeutics' Other Working Capital Changes was $71,649 in Q2 2026, down 41.2% from $121,783 a year earlier.
Powered by 
Analysis
Relmada Therapeutics (RLMD) Other Working Capital Changes (2012 - 2026) Analysis & Trends
On a trailing twelve-month basis, Relmada Therapeutics' Other Working Capital Changes was -$831,400 through Jun 30, 2026; for FY2025, it was -$88,785.
- In earlier years, Other Working Capital Changes was $324,213 in FY2024 (-90.3%), $3.35 million in FY2023 (-50.3%), $6.75 million in FY2022 and -$10.4 million in FY2021.
- Quarterly Other Working Capital Changes has moved between -$8.59 million (Q4 2021) and $6.24 million (Q1 2022) over five years.
- The best year-over-year quarter for Other Working Capital Changes over five years was Q3 2023 (growth of 41.5%); the worst was Q4 2025 (a decline of 79.2%).
- Per Business Quant data, RLMD's Other Working Capital Changes in the three quarters before Q2 2026 was -$402,430 (Q1 2026), $204,710 (Q4 2025) and -$705,329 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn |
| 10 | Relmada Therapeutics | 473.10 Mn | -85.48 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 71,649.00 |
| Mar 31, 2026 | -402,430.00 |
| Dec 31, 2025 | 204,710.00 |
| Sep 30, 2025 | -705,329.00 |
| Jun 30, 2025 | 121,783.00 |
| Mar 31, 2025 | 293,089.00 |
| Dec 31, 2024 | 982,145.00 |
| Sep 30, 2024 | -1.30 Mn |
| Jun 30, 2024 | 204,312.00 |
| Mar 31, 2024 | 432,723.00 |
| Dec 31, 2023 | 1.65 Mn |
| Sep 30, 2023 | 1.14 Mn |
| Jun 30, 2023 | -897,107.00 |
| Mar 31, 2023 | 1.46 Mn |
| Dec 31, 2022 | -1.61 Mn |
| Sep 30, 2022 | 805,340.00 |
| Jun 30, 2022 | 1.32 Mn |
| Mar 31, 2022 | 6.24 Mn |
| Dec 31, 2021 | -8.59 Mn |
| Sep 30, 2021 | -1.17 Mn |
API Access
Relmada Therapeutics Other Working Capital Changes API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-working-capital-changes&ticker=RLMD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-working-capital-changes", "ticker": "RLMD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-working-capital-changes&ticker=RLMD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();